期刊文献+

大脑胶质瘤病的MRI特点研究 被引量:2

Study on MR imaging manifestations of gliomatosis cerebri
原文传递
导出
摘要 目的探讨大脑胶质瘤病的MRI特点。方法对14例经手术(或活检)、病理证实的大脑胶质瘤病患者的MRI和临床资料进行回顾性分析。结果大脑胶质瘤病的临床表现以头痛(12/14)和癫痫(7/14)为常见,后期多出现严重颅高压征象。MRI提示病灶呈多灶性生长9例,弥漫性生长5例,至少累及2叶脑组织。T1WI呈等或稍低信号灶,T2WI为等或高信号灶,轻至中度水肿,占位效应轻。增强扫描常见肿瘤轻度强化。星形胶质瘤Ⅰ级7例,Ⅱ级5例,少枝胶质瘤Ⅱ级1例,少枝一星形混合胶质瘤Ⅱ级1例。结论大脑胶质瘤病的影像学表现与某些神经系统病变有类似和重叠之处,但通过影像与临床表现的结合,有利于该病变的诊断与鉴别诊断。 Objective To investigate the magnetic resonance imaging (MRI) features of gliomatosis cerebri. Methods MRI and clinical data of 14 cases who were definitely diagnosed as gliomatosis cerebri by the operation (or biopsy) and pathological examination, were retrospectively analyzed. Results The primary manifestations of gliomatosis cerebri were dominated by headache (12/14) and seizure (7/14), and symptoms and signs of severe intracranial hypertension occurred frequently at the later stage. MRI scan indicated that at least two cerebral lobes were involved by multiple lesions of 9 cases and diffuse-type tumors of 5 cases. The lesions were isointense or slightly hypointense on T1-weighted images (T1WI) and isointense or hyperintense on T2-weighted images (T2WI). The severity of edema was mild or moderate and mass effect, mild. Contrast-enhanced CT scan showed that tumors were frequently slightly enhanced. A total of 12 cases with low-grade astrocytomas (grade Ⅰ : 7 cases; grade Ⅱ : 5 cases), 1 case with grade Ⅱ oligodendroglioma and 1 case with grade Ⅱ mixed oligo-astrocytoma were pathologically proved. Conclusion MRI findings of gliomatosis cerebri are analogous to or overlap with some lesions of the nervous system, but with the combined application of imaging and clinical manifestations, diagnosis and differential diagnosis of this disease shall be more effective.
出处 《中华神经医学杂志》 CAS CSCD 2007年第10期1002-1004,共3页 Chinese Journal of Neuromedicine
关键词 大脑胶质瘤病 磁共振成像 临床特点 Gliomatosis cerebri Magnetic resonance imaging Clinical features
  • 相关文献

参考文献7

  • 1Nevin S. Gliomatosis cerebri[J]. Brain, 1938, 6(1): 170-191.
  • 2Chamberlain MC. Gliomatosis cerebri better definition, better treatment[J]. Neurology, 2004, 63(2): 204-205.
  • 3Vates GE, Chang S, Lambom KR. et al. Gliomatosis cerebri: a review of 22 cases [J]. Neurosurgery, 2003, 53(2): 261-271.
  • 4潘初,朱文珍,黄博,夏黎明,漆剑频,王承缘.脑胶质瘤病的MRI及MRS研究[J].放射学实践,2004,19(9):631-634. 被引量:6
  • 5Levin N, Gmomori JM, Siegal T. Chemotherapy as initial treatment in gliomatosis cerebri results with temozolomide [J]. Neurology, 2004, 63(2): 354-356.
  • 6张华楸,舒凯,叶飞,郭东升,牛洪泉,雷霆,李龄.脑胶质瘤病的诊断和治疗[J].中华神经医学杂志,2005,4(6):582-584. 被引量:10
  • 7张义,吴劲松,张福林,潘力,邬剑军,陈宏.脑胶质瘤病[J].中华神经外科杂志,2001,17(1):7-10. 被引量:11

二级参考文献17

  • 1潘初,朱文珍,黄博,夏黎明,漆剑频,王承缘.脑胶质瘤病的MRI及MRS研究[J].放射学实践,2004,19(9):631-634. 被引量:6
  • 2Nevin S. Gliomatosis cerebri[J]. Brain,1938,6(1) :170-191.
  • 3Carpio-O′Donovan R,Korah I,Salazar A,et al. Gliomatosis cerebri [J]. Radiology, 1996,198(5) :831-835.
  • 4Peretti-Viton P, Brunel H, Chinot O, et al. Histological and MR correlations in Gliomatosis cerebri[J]. J Neurooncol, 2002,59 (3):249-259.
  • 5Hara A,Sakai N,Yamada H,et al. Assessment of proliferative potential in gliomatosis cerebri[J]. J Neurol,1991,38(2) :280-282.
  • 6Vates GE,Chang S, Lamborn KR,et al. Gliomatosis cerebri:a review of 22 cases[J]. Neurosurgery,2003,53(2) :261-271.
  • 7Martin Bendszus, Monika Warmuth-Metz, Rüdiger Klein, et al.MR spectroscopy in gliomatosis cerebri[J]. AJNR, 2000,21 (2)375-380.
  • 8Shin Y M,AJR Am J Roentgenol,1993年,161卷,859页
  • 9Chamberlain MC. Gliomatosis cerebri: better definition, better treatment[J]. Neurology, 2004, 63(2): 204-205.
  • 10Vates GE, Chang S, Lamborn KR, et al. Gliomatosis cerebri: a review of 22 cases[J]. Neurosurgery, 2003, 53(2): 261-271.

共引文献23

同被引文献42

  • 1Adams JM, Difazio LT, Rolandelli RH, et al. HIF- 1: a key mediator in hypoxia[J]. Acta Physiol Hung, 2009, 96(1): ! 9-28.
  • 2Lu H, Li Y, Shu M, et al. Hypoxia-inducible factor-lalpha blocks differentiation of malignant gliomas[J]. FEBS J, 2009, 276(24): 7291-7304.
  • 3Henze AT, Riedel J, Diem T, et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible fitctors[J]. Cancer Res, 2010, 70(1): 357-366.
  • 4Purow B, Schiff D. Advances in the genetics of glioblastoma: are we reaching critical mass? [J]. Nat Rev Neurol, 2009, 5 (8): 419-426.
  • 5Cheng TL, Chang WT. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in m~mmalian cells [J]. Methods Mol Biol, 2007, 408: 223-241.
  • 6Fujiwara S, Nakagawa K, Harada H, et al. Silencing hypoxia-inducible factor-lalpha inhibiIs cell migration and invasion under hypoxic envi-ronment in malignant gliomas [J]. Int J Oncol, 2007, 30 (4): 793-802.
  • 7Soeda A, Park M, Lee D, et al. Hypoxia promotes expansion of the CD 133-positive glioma stem cells through activation of HIF-1 alpha [J]. Oncogene, 2009, 28(45): 3949-3959.
  • 8Liu Y, Li YM, Tian RF, et al. The expression and significance of HIF-lalpha and GLUT-3 in glioma[J]. Brain Res, 2009, 22(1304): 149-154.
  • 9Argyriou AA, Giannopoulou E, Kalofonos HP. Angiogenesis and anti-angiogenic mclecularly targeted therapies in malignant gliomas[J]. Oncology, 2009, 77(1): 1-11.
  • 10Gillespie DL, Flynn 5rR, Ragel BT, et al. Silencing of HIF-1 alpha by RNA interference in human glioma cells in vitro and in vivo [J]. Methods Mol Biol, 2009, 487: 283-301.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部